Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
413 studies found for:    Open Studies | "Stomach Neoplasms"

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Stomach Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Comparison of SEEOX and SOX Regimens in Unresectable Gastric Cancer Patients
Conditions: Stomach Neoplasms;   Gastric Cancer
Interventions: Drug: oxaliplatin;   Drug: etoposide;   Drug: pharmorubicin;   Drug: S-1
2 Unknown † Study of Oxaliplatin, Calcium Folinate, and 5-Fluorouracil as Neoadjuvant Chemotherapy for Resectable Advanced Gastric Cancer
Conditions: Stomach Neoplasms;   Gastric Cancer
Intervention: Drug: mFOLFOX
3 Unknown † Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer
Condition: Stomach Neoplasms
Intervention: Drug: S-1,Docetaxel
4 Unknown † Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma
Condition: Stomach Neoplasms
Intervention: Drug: S-1,oxaliplatin
5 Not yet recruiting Randomized Controlled Trials Comparing Clinical Outcomes of 3D Versus 2D Laparoscopic Surgery for Gastric Cancer
Condition: Stomach Neoplasms
Interventions: Procedure: 3D Laparoscopic Surgery;   Procedure: 2D Laparoscopic Surgery
6 Unknown † S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer
Condition: Stomach Neoplasms
Intervention: Drug: S-1, capecitabine
7 Recruiting Intracorporeal Versus Extracorporeal Roux-en-Y Esophagojejunostomy During Laparoscopic Total Gastrectomy for Gastric Cancer
Conditions: Stomach Neoplasms;   Minimally Invasive Surgery;   Anastomosis
Interventions: Procedure: Intracorporeal Roux-en-Y esophagojejunostomy;   Procedure: Extracorporeal Roux-en-Y esophagojejunostomy
8 Not yet recruiting Randomized Controlled Trials on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Middle or Upper Third Gastric Cancer
Condition: Stomach Neoplasms
Interventions: Procedure: D2 lymphadenectomy including No. 10;   Procedure: D2 lymphadenectomy excluding No. 10
9 Unknown † An Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose 5-Fluorouracil and Leucovorin(HDFL)to Treat Inoperable Advanced or Metastatic Gastric Cancer
Condition: Stomach Neoplasms
Intervention: Drug: Taxotere, Fluorouracil, Leucovorin
10 Not yet recruiting Prospective Study on Modified Delta-shaped Gastroduodenostomy in Totally Laparoscopic Surgery for Distal Gastric Cancer
Condition: Stomach Neoplasms
Interventions: Procedure: Totally laparoscopic distal gastrectomy;   Procedure: Laparoscopy-assisted distal gastrectomy
11 Recruiting 64Cu DOTA-Trastuzumab PET in Studying Patients With Gastric Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction;   Diffuse Adenocarcinoma of the Stomach;   Intestinal Adenocarcinoma of the Stomach;   Mixed Adenocarcinoma of the Stomach;   Recurrent Gastric Cancer;   Stage IA Gastric Cancer;   Stage IB Gastric Cancer;   Stage IIA Gastric Cancer;   Stage IIB Gastric Cancer;   Stage IIIA Gastric Cancer;   Stage IIIB Gastric Cancer;   Stage IIIC Gastric Cancer
Interventions: Radiation: copper Cu 64-DOTA-trastuzumab;   Device: positron emission tomography;   Other: laboratory biomarker analysis
12 Recruiting A Study Comparing Billroth II With Roux-en-Y Reconstruction for Gastric Cancer
Conditions: Gastric Cancer;   Stomach Cancer;   Gastrectomy
Intervention: Procedure: Roux-en-Y or Billroth II
13 Not yet recruiting Endoscopic Ultrasonographic Staging and Conventional Endoscopic Staging for Depth of Invasion for Early Gastric Cancer
Conditions: Gastric Tumor;   Early Gastric Cancer
Intervention:
14 Recruiting A Phase 3 Study to Compare Efficacy and Safety of DHP107 Versus Taxol® in Patients With Metastatic or Recurrent Gastric Cancer After Failure of First-line Chemotherapy
Condition: Stage IV Gastric Cancer
Intervention: Drug: Paclitaxel
15 Recruiting Early Onset and Familial Gastric Cancer Registry
Condition: Gastric Cancer
Intervention: Behavioral: questionnaires
16 Unknown † Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: capecitabine;   Drug: oxaliplatin;   Drug: tegafur-gimeracil-oteracil potassium
17 Not yet recruiting Phase 3 Study of Xelox Followed by Maintenance Capecitabine in the Advanced Gastric Cancer
Condition: Stomach Neoplasms
Intervention: Drug: Capecitabine
18 Unknown † A Study of Oraxol® in Gastric Cancer Patients
Conditions: Advanced Metastatic Gastric Cancer;   Recurrent Gastric Cancer
Intervention: Drug: Paclitaxel
19 Recruiting Efficacy of Laparoscopic Subtotal Gastrectomy With D2 Lymph Node Dissection for Locally Advanced Gastric Cancer
Condition: Gastric Cancer
Interventions: Procedure: Laparoscopic gastrectomy;   Procedure: Open gastrectomy
20 Recruiting Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality
Conditions: Helicobacter Pylori Infections;   Atrophic Gastritis;   Gastric Cancer
Intervention: Drug: Triple therapy
To Top

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
† Indicates status has not been verified in more than two years